FDA has accepted and granted Priority Review to the biologics license application for ifinatamab deruxtecan in adults with ...
GSK has reported encouraging early clinical data from the global phase I BEHOLD-1 trial of mocertatug rezetecan, a ...
Researchers at MD Anderson identified DPY30 as a key biomarker and epigenetic regulator that enables pancreatic tumors to ...
A new study led by UCL researchers suggests that making cancer cells more visible to the immune system could broaden the ...
Researchers from MD Anderson identified DHODH as a key metabolic driver of radiotherapy resistance in lung cancer. Radiation ...
Neladalkib has been submitted for FDA review in TKI pre-treated advanced ALK-positive NSCLC, based on data from the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results